Analyzing Eli Lilly's Q3 Results

Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Experts are predicting strong growth driven by the strong demand of Lilly's blockbuster drugs, particularly its insulin portfolio. However, th

read more